Creatinine clearance, cystatin C, beta2-microglobulin and TATI as markers of renal function in patients with proteinuria

Journal of Nephrology

Volumn 25, Issue 6, 2012, Pages 976-982

  Tramonti, Gianfranco ^a   Cipollini, Ilaria ^a   Annichiarico, Carmela ^a   Lorusso, Paolo ^a   Panicucci, Erica ^a   Mariani, Giuliano ^a   Barsotti, Giuliano ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

2 microglobulin; Creatinine clearance; Cystatin C; GFR; Proteinuria; TATI

Indexed keywords

APROTININ; BETA 2 MICROGLOBULIN; CYSTATIN C; PENTETATE TECHNETIUM TC 99M;

ADULT; ARTICLE; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION TEST; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEINURIA; URINALYSIS;

ADOLESCENT; ADULT; AGED; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CARRIER PROTEINS; CREATININE; CYSTATIN C; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEINURIA; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84870606656     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000078     Document Type: Article

References (27)

1. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med. 1998;339(20):1448-1456.
2. Ruggenenti P, Remuzzi G. The role of protein traffic in the progression of renal diseases. Annu Rev Med. 2000;51(1): 315-327.
3. Brunskill NJ. Mechanisms of albumin uptake by proximal tubular cells. Am J Kidney Dis. 2001;37(1)(Suppl 2):S17-S20.
4. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461-470.
5. Kyhse-Andersen J, Schmidt C, Nordin G, et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem. 1994;40(10): 1921-1926.
6. Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem. 2002;48(5): 699-707.
7. Kazama JJ, Kutsuwada K, Ataka K, Maruyama H, Gejyo F. Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron. 2002;91(1):13-20.
8. Tramonti G, Donadio C, Ferdeghini M, et al. Serum tumourassociated trypsin inhibitor (TATI) and renal function. Scand J Clin Lab Invest. 1996;56(7):653-656.
9. Tramonti G, Ferdeghini M, Donadio C, et al. Tumor-associated trypsin inhibitor (TATI) and renal function. Kidney Int Suppl. 1997;63:S179-S181.
10. Tramonti G, Ferdeghini M, Donadio C, et al. Serum levels of tumor associated trypsin inhibitor (TATI) and glomerular filtration rate. Ren Fail. 1998;20(2):295-302.
11. Tramonti G, Ferdeghini M, Annichiarico C, et al. Assessment of tumor-associated trypsin inhibitor (TATI) as a marker of renal function. J Nephrol. 2003;16(5):663-672.
12. Bernier GM, Conrad ME. Catabolism of human beta-2- microglobulin by the rat kidney. Am J Physiol. 1969;217(5): 1359-1362.
13. 2-Microglobulin: its significance in the evaluation of renal function. Kidney Int. 1987;32(5):635-641.
14. Carrie BJ, Golbetz HV, Michaels AS, Myers BD. Creatinine: an inadequate filtration marker in glomerular diseases. Am J Med. 1980;69(2):177-182.
15. Berlyne GM, Varley H, Nilwarangkur S, Hoerni M. Endogenous creatinine clearance and glomerular filtration rate. Lancet. 1964;ii(7365):874-876.
16. Branten AJW, Vervoort G, Wetzels JFM. Serum creatinine is a poor marker of GFR in nephrotic syndrome. Nephrol Dial Transplant. 2005;20(4):707-711.
17. Bianchi C. Measurement of the glomerular filtration rate. Prog Nucl Med. 1972;2:21-53.
18. Bianchi C. Non-invasive methods for the measurement of renal function. In: Duarte CG, ed. Renal function tests. Boston, MA: Little, Brown and Company; 1980:65-84.
19. Bianchi C, Bonadio M, Donadio C, Tramonti G, Figus S. Measurement of glomerular filtration rate in man using DTPA- 99mTc. Nephron. 1979;24(4):174-178.
20. Perkins BA, Nelson RG, Ostrander BEP, et al. Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol. 2005;16(5):1404-1412.
21. Jovanoví D, Krstivojeví P, Obradoví I, Durdeví V, Dukanoví L. Serum cystatin C and beta2-microglobulin as markers of glomerular filtration rate. Ren Fail. 2003;25(1):123-133.
22. Hojs R, Bevc S, Ekart R, Gorenjak M, Puklavec L. Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease. Ren Fail. 2008;30(2):181-186.
23. Donahue RP, Stranges S, Rejman K, Rafalson LB, Dmochowski J, Trevisan M. Elevated cystatin C concentration and progression to pre-diabetes: the Western New York study. Diabetes Care. 2007;30(7):1724-1729.
24. Ledson T, Howse MLP, Roberts NB, Kemp GJ, Williams PS. Cystatin C as a surrogate for glomerular filtration rate in the presence of proteinuria. Nephrol Dial Transplant Plus. 2008;3:194-195.
25. Bethea M, Forman DT. Beta 2-microglobulin: its significance and clinical usefulness. Ann Clin Lab Sci. 1990;20(3):163-168.
26. Sjöström P, Tidman M, Jones I. Determination of the production rate and nonrenal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest. 2005;65(2):89-91.
27. Schück O, Teplan V, Jabor A, Stollova M, Skibova J. Glomerular filtration rate estimation in patients with advanced chronic renal insufficiency based on serum cystatin C levels. Nephron Clin Pract. 2003;93(4):c146-c151.